J Cannabis Ther 2003(2):63-71

Meeting report

Cannabinoids and Pain Management Symposium: American Academy of Pain Management 13th Annual Clinical Meeting, 2002, Reno, NV, USA

Author
J. McPartland, E. Russo, D. Hadorn, W. Notcutt, M. Ware, J. H. Atkinson

Abstract
PROGRESS IN NEUROBIOLOGY RELATED TO CANNABINOIDS. J.M. McPartland, MS, DO, Faculty of Health & Environmental Science, UNITEC, Private Bag 92025, Mt. Albert, Auckland, New Zealand.

CANNABIS: FROM RAW PLANT TO PHARMACEUTICAL PRODUCTS. Ethan Russo, MD, Montana Neurobehavioral Specialists, 900 North Orange St., Missoula, MT 59802, USA (E-mail: Erusso@ blackfoot.net).

TRIAL DESIGNS FOR CANNABINOIDS. David Hadorn, GWPharmaceuticals, Porton Down, Salisbury, England (E-mail: dhadorn@ fastmail.fm).

RESULTS FROM TRIALS OF CANNABIS BASED MEDICAL EXTRACTS. William Notcutt, James Paget Hospital, Lowestoft Road, Great Yarmouth, Norfolk, NR31 6LA, UK.

CANADIAN CANNABIS: GRANTS, TRIALS AND OUTCOMES. Mark Ware, BA, MBBS, MRCP(UK), MSc, McGill University, Montreal (E-mail: Mware@total.net).

UNIVERSITY OF CALIFORNIA CENTER FOR MEDICINAL CANNABIS RESEARCH (CMCR). J. Hampton Atkinson, University of California San Diego (E-mail: jhatkinson@ucsd.edu).

CURRENT AND PLANNED TRIALS-GW PHARMACEUTICALS. David Hadorn,GWPharmaceuticals, Porton Down, Salisbury, England (E-mail: dhadorn@fastmail.fm).

[ PDF do texto completo ]